This book tells the story of one of medicine’s most (in)famous treatments: the neurosurgical operation commonly known as lobotomy. Invented by Portuguese neurologist Egas Moniz in 1935, lobotomy or psychosurgery became widely used in a number of countries, including Denmark, where the treatment had a major breakthrough. In fact, evidence suggests that more lobotomies were performed in Denmark than any other country. However, the reason behind this unofficial world record has not yet been fully understood. Lobotomy Nation traces the history of psychosurgery and its ties to other psychiatric treatments such as malaria fever therapy, Cardiazol shock and insulin coma therapy, but it also situates lobotomy within a broader context. The book argues that the rise and fall of lobotomy is not just a story about psychiatry, it is also about society, culture and interventions towards vulnerable groups in the 20th century.

American Lobotomy studies a wide variety of representations of lobotomy to offer a rhetorical history of one of the most infamous procedures in the history of medicine. The development of lobotomy in 1935 was heralded as a “miracle cure” that would empty the nation’s perennially blighted asylums. However, only twenty years later, lobotomists initially praised for their “therapeutic courage” were condemned for their barbarity, an image that has only soured in subsequent decades. Johnson employs previously abandoned texts like science fiction, horror film, political polemics, and conspiracy theory to show how lobotomy’s entanglement with social and political narratives contributed to a powerful image of the operation that persists to this day. The book provocatively challenges the history of medicine, arguing that rhetorical history is crucial to understanding medical history. It offers a case study of how medicine accumulates meaning as it circulates in public culture and argues for the need to understand biomedicine as a culturally situated practice.

In this heartfelt memoir from one of the youngest recipients of the transorbital lobotamy, Howard Dully shares the story of a painfully dysfunctional childhood, a misspent youth, his struggle to claim the life that was taken from him, and his redemption. At twelve, Howard Dully was guilty of the same crimes as other boys his age: he was moody and messy, rambunctious with his brothers, contrary just to prove a point, and perpetually at odds with his parents. Yet somehow, this normal boy became one of the youngest people on whom Dr. Walter Freeman performed his barbaric transorbital—or ice pick—lobotomy. Abandoned by his family within a year of the surgery, Howard spent his teen years in mental institutions, his twenties in jail, and his thirties in a bottle. It wasn’t until he was in his forties that Howard began to pull his life together. But even as he began to live the “normal” life he had been denied, Howard struggled with one question: Why? There were only three people who would know the truth: Freeman, the man who performed the procedure; Lou, his cold and demanding stepmother who brought Howard to the doctor’s attention; and his father, Rodney. Of the three, only Rodney, the man who hadn’t intervened on his son’s behalf, was still living. Time was running out. Stable and happy for the first time in decades, Howard began to search for answers. Through his research, Howard met other lobotomy patients and their families, talked with one of Freeman’s sons about his father’s controversial life’s work, and confronted Rodney about his complicity. And, in the archive where the doctor’s files are stored, he finally came face to face with the truth. Revealing what happened to a child no one—not his father, not the medical community, not the state—was willing to protect, My Lobotomy exposes a shameful chapter in the history of the treatment of mental illness. Yet, ultimately, this is a powerful and moving chronicle of the life of one man.

"Yet, many of the most important medical figures during Freeman's time lent their support to his work, effectively pulling lobotomy into the mainstream of medical practice. Many of Freeman's patients, some of them writing and speaking with astonishing clarity, observed how their lobotomies had changed them for the better. So how is it that both physicians and patients supported a procedure that today seems outrageous, even barbaric? And why did Freeman remain a forceful proponent of lobotomy even after most other physicians abandoned it in favor of newer forms of psychiatric treatment?".

The diet and weight-loss industry is worth $66 billion – billion!! The estimated annual health care costs of obesity-related illness are 190 billion or nearly 21% of annual medical spending in the United States. But how did we get here? Is this a battle we can’t win? What changes need to be made in order to scale back the incidence of obesity in the US, and, indeed, around the world? Here, Jonathan Engel reviews the sources of the problem and offers the science behind our modern propensity toward obesity. He offers a plan for helping address the problem, but admits that it is, indeed, an uphill battle. Nevertheless, given the magnitude of the costs in years of life and vigor lost, it is a battle worth fighting. Fat Nation is a social history of obesity in the United States since the second World War. In confronting this familiar topic from a historical perspective, Jonathan Engel attempts to show that obesity is a symptom of complex changes that have transpired over the past half century to our food, our living habits, our life patterns, our built environments, and our social interactions. He offers readers solid grounding in the known science underlying obesity (genetic set points, complex endocrine feedback loops, neurochemical messengering) but then makes the novel argument that obesity is a result of the interaction of our genes with our environment. That is, our bodies have always been programmed to become obese, but until recently never had the opportunity to do so. Now, with cheap calories ubiquitous (particularly in the form of sucrose), unwalkable physical spaces, deteriorating rituals and norms surrounding eating, and the withering of cooking skills, nearly every American daily confronts the challenge of not putting on weight. Given the outcomes, though, for those who are obese, Engel encourages us to address the problems and offers suggestions to help remedy the problem.

Making Mental Health: A Critical History historicises mental health by examining the concept from the ‘madness’ of the late nineteenth century to the changing ideas about its contemporary concerns and status. It argues that a critical approach to the history of psychiatry and mental health shows them to constitute a dual clinical-political project that gathered pace over the course of the twentieth century and continues to resonate in the present. Drawing on scholarship across several areas of historical inquiry as well as historical and contemporary clinical literature, the book uses a thematic approach to highlight decisive moments that demonstrate the stakes of this engagement in Anglo-American contexts. By tracing the (unfinished) history of institutions, the search for cures for psychiatric distress, the growing interest of the nation-state in mental health, the history of attempts to globalise psychiatry, the controversies over the politics of diagnostic categories that erupted in the 1960s and 1970s, and the history of theorising about the relationship between the psyche and the market, the book offers a comprehensive account of the evolution of mental health into a commonplace concern. Addressing key questions in the fields of history, medical humanities, and the social sciences, as well as in the psychiatry disciplines themselves, the book is an essential contribution to an ongoing conversation about mental distress and its meanings.

Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers non-technical summaries of the most recent, double-blind, placebo-controlled studies with MDMA, psilocybin, LSD, and ayahuasca • Includes the work of Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob’s research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate’s attempt to transport this plant medicine to a clinical setting with the help of Canada’s Department of National Health. Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.